MaxCyte IPO Presentation Deck
Offering Summary
Issuer:
Exchange / Ticker:
Base Offering Size:
Over-Allotment Option:
Price Range:
Lock-Up Provision:
Use of Proceeds:
Active Bookrunners:
Co-Managers:
Expected Pricing Date:
M MaxCyte
July 2021
MaxCyte, Inc.
NASDAQ/MXCT (current listing on AIM: MXCT)
12,000,000 shares (100% primary)
1,800,000 shares (100% primary)
$11.50 - $13.50 per share
90 days for the Company, directors and officers
Various R&D initiatives, including commercialization of the VLX platform (under the ExPERT platform umbrella)
Expansion of manufacturing capabilities and investment in manufacturing automation
Expansion of sales and marketing, business development and field application scientist teams
Working capital and general corporate purposes
Cowen, Stifel and William Blair
BTIG and Stephens
July 29, 2021 (post-market close)
·
·
H
CONFIDENTIALView entire presentation